HomeBusinessPraxis Precision Medicines reports Phase 2/3 study results for vormatrigine in epilepsy Praxis Precision Medicines reports Phase 2/3 study results for vormatrigine in epilepsy June 1, 2026byadmin Praxis Precision Medicines reports Phase 2/3 study results for vormatrigine in epilepsy Source link
Colorado progressive Rutinel wins Democratic primary to challenge Republican Gabe Evans in key House race Colorado progressive Rutinel wins Democratic primary to challenge Republican Gabe Evans in key House race Source link
Shattuck Labs prices $75M public offering at $4 per share Shattuck Labs prices $75M public offering at $4 per share Source link
Warsh-led Fed expected to hold interest rates steady Warsh-led Fed expected to hold interest rates steady Source link